Market Place
Sourcing Support
Novo Nordisk`s Ozempic faces EU review for potential eye disease connection
18 Dec 2024 //
REUTERS
FDA warns online vendors selling unapproved weight-loss drugs
18 Dec 2024 //
REUTERS
Novo`s Ozempic faces scrutiny over potential link to rare eye disease
17 Dec 2024 //
REUTERS
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
14 Dec 2024 //
BIOSPACE
Cellev8 Nutrition Launches First GLP1 Support Gummy
12 Dec 2024 //
ACCESSWIRE
PeptiDream Shows Oral Myostatin Inhibitors Prevent Lean Mass Loss
12 Dec 2024 //
BUSINESSWIRE
FDA chief Defends Obesity Work Before Senate RFK Jr Criticism
06 Dec 2024 //
REUTERS
Lilly`s Zepbound Beats Wegovy In Weight Loss Trial: 20.2% Vs. 13.7%
05 Dec 2024 //
PR NEWSWIRE
Novo India execs urge early Wegovy launch as weight-loss rival
03 Dec 2024 //
ECONOMICTIMES
BioNxt Solutions Develops Sublingual Thin-Film for Semaglutide
02 Dec 2024 //
ACCESSWIRE
ProLynx Publishes Once Monthly Semaglutide in PNAS
02 Dec 2024 //
PR NEWSWIRE
Novo Nordisk launches obesity drug Wegovy in China
19 Nov 2024 //
REUTERS
Helix Introduces Precision Model for Semaglutide Weight Loss
13 Nov 2024 //
PR NEWSWIRE
US Minority Veterans Face Unequal Access to Ozempic, Wegovy
11 Nov 2024 //
REUTERS
Novo expects high demand for its obesity drugs in India
07 Nov 2024 //
REUTERS
Novo reports mixed sales on GLP-1 stalwarts Ozempic, Wegovy
06 Nov 2024 //
FIERCE PHARMA
Novo affirms 25% weight-loss for experimental drug CagriSema
06 Nov 2024 //
REUTERS
Novo`s Wegovy weight-loss drug sales beat forecast, shares jump
06 Nov 2024 //
REUTERS
Select Trial: Semaglutide Reduces Hospital Admissions in Obesity
03 Nov 2024 //
PR NEWSWIRE
FDA expunges all Ozempic, Wegovy doses from shortage list
02 Nov 2024 //
FIERCE PHARMA
Novo Nordisk`s semaglutide delivers in phase 3 MASH study
01 Nov 2024 //
FIERCE PHARMA
Novo Nordisk Faces FDA Write-Up Over Semaglutide Plant Issues
31 Oct 2024 //
FIERCE PHARMA
Tiziana Life Sciences Announces Ozempic & Anti-CD3 Study Results
30 Oct 2024 //
GLOBENEWSWIRE
STEP 9 Study: Semaglutide Reduces OA Pain in Obesity Patients
30 Oct 2024 //
PR NEWSWIRE
Novo’s Semaglutide Linked to Reduced Alzheimer’s Risk in Study
25 Oct 2024 //
BIOSPACE
Novo asks US to stop compounding weight-loss drug copies
24 Oct 2024 //
REUTERS
Novo oral diabetes drug cuts heart-related risks by 14% in study
22 Oct 2024 //
REUTERS
Chinese insulin maker’s GLP-1 bests Ozempic in ph. 2, company says
15 Oct 2024 //
FIERCE BIOTECH
Wegovy maker Novo bets big on talent, AI partnerships in India
11 Oct 2024 //
ECONOMICTIMES
WeightWatchers to offer compounded version of Novo`s weight-loss drug
08 Oct 2024 //
REUTERS
Novo settles with Mylan over potential Ozempic generic
07 Oct 2024 //
FIERCE PHARMA
Novo CEO agrees to discuss potential GLP-1 price cuts with PBMs
26 Sep 2024 //
FIERCE PHARMA
US Senator Sanders says middlemen won`t punish Novo
25 Sep 2024 //
REUTERS
Novo CEO, Sanders to Face Off Over US Prices for Ozempic and Wegovy
24 Sep 2024 //
BIOSPACE
Novo: Ozempic Eligible For US Price Negotiations Soon
23 Sep 2024 //
REUTERS
Novo Nordisk Shares Drop On Disappointing Obesity Pill Data
21 Sep 2024 //
REUTERS
EU regulator backs use of Novo`s Wegovy for obesity-related heart condition
20 Sep 2024 //
REUTERS
Novo Nordisk: Wegovy® Recommended For Label Update In EU
19 Sep 2024 //
GLOBENEWSWIRE
Hims & Hers offers compounded Wegovy for $99 a month to select professions
18 Sep 2024 //
REUTERS
Novo Nordisk Reports Strong Weight Loss Results For Dual-Acting Oral Drug
11 Sep 2024 //
FIERCE BIOTECH
Enforcement Report - Week of September 11, 2024
11 Sep 2024 //
FDA
Novo Nordisk To Present New Diabetes And Obesity Data At EASD Meeting
06 Sep 2024 //
PR NEWSWIRE
Fake Ozempic: Batch Numbers Help Spread Dangerous Weight Loss Drugs
05 Sep 2024 //
REUTERS
FDA Confirms Para IV Patent Litigation for (Rybelsus) Semaglutide
04 Sep 2024 //
FDA
From the Neuland Reading Room: Peptide Trends in 2024
02 Sep 2024 //
PRESS RELEASE
Novo Nordisk`s Ozempic shortage expected to continue into Q4
02 Sep 2024 //
REUTERS
Novo rekindles heart failure hopes for semaglutide with new pooled analysis
31 Aug 2024 //
FIERCE PHARMA
Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145B Annually
28 Aug 2024 //
BIOSPACE
ProLynx Reports Preclinical Results Of Monthly Semaglutide
21 Aug 2024 //
GLOBENEWSWIRE
New Study Adds To Ongoing Debate On Suicidal Ideation Risk For Ozempic
20 Aug 2024 //
FIERCE PHARMA
Novo Nordisk plans new $220M raw ingredients plant in Denmark
16 Aug 2024 //
FIERCE PHARMA
DiagnaMed Explores Brain Health AI For Weight Loss Drugs Like Semaglutide
15 Aug 2024 //
GLOBENEWSWIRE
Novo Nordisk Plans 2024 FDA Filing For Weekly Insulin-Semaglutide Combo
13 Aug 2024 //
FIERCE PHARMA
Novo`s older obesity drug shows biological effect on Alzheimer`s patients
31 Jul 2024 //
REUTERS
Novo Nordisk’s Ozempic Could Help Curb Cigarette Use in Diabetics
30 Jul 2024 //
BIOSPACE
Compounded Injectable Semaglutide Dosing Errors Cause Adverse Events
29 Jul 2024 //
CONTRACT PHARMA
Wegovy Label Updated To Include Cardiovascular Risk Reduction
25 Jul 2024 //
GLOBENEWSWIRE
Novo New Facility With 200-Acre Land Buy In Denmark Amid Weight Loss Drug Boom
23 Jul 2024 //
FIERCE PHARMA
Patients on weight-loss drugs should inform doctor before surgery, EU regulator
13 Jul 2024 //
REUTERS
Novo Nordisk`s Ozempic cuts dementia risk vs. Merck`s Januvia
12 Jul 2024 //
FIERCE PHARMA
